Bharat Biotech debunks 'political pressure' claims regarding authorisation of Covaxin. It asserts that 'scientific approach was followed.'
A recent report by STAT has emerged about Covaxin and its maker, Bharat Biotech. The investigation suggests that the Hyderabad-based Covaxin developer, Bharat Biotech, had skipped some steps of the Central Drug Standards Control Organization (CDSCO).
According to the report, the Covaxin was rushed due to 'political pressure,' and as a result, it skipped various safeguards in the process before making it available for people.
THIS IS A BREAKING STORY. UPDATES SOON
Market Outlook: Technical Call Of The Day & Top 5 Stocks In Focus For December 4, 2025
Russian President Vladimir Putin's 2-Day India Visit Begins Today; Know What's On Agenda - 10 Points
West Bengal CM Mamata Banerjee Slams Amit Shah For SIR Ahead Of Elections
TRAI Blocks 21 Lakh Mobile Numbers, 1 Lakh Entities For Spam & Fraud
